文献速递肝病消化道出血

新型FIPS评分优化TIPS术后生存预测

Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
PubMed 文献 · J Hepatol · 2021-01-26

该回顾性研究纳入1871例因腹水或食管胃静脉曲张出血二级预防行TIPS的患者,开发了基于年龄、胆红素、白蛋白和肌酐的FIPS评分。FIPS能识别高危患者(训练集中位生存5.0个月),在验证集中得到确认,且优于Child-Pugh、MELD等评分,但在早期TIPS患者中区分度不足。

要点

  • FIPS评分基于年龄、胆红素、白蛋白和肌酐四项指标。
  • FIPS识别的高危患者中位生存期在训练集为5.0个月。
  • FIPS对择期TIPS的预后区分优于Child-Pugh和MELD评分。

核心结论

  • FIPS评分在识别择期TIPS术后高危患者方面优于现有评分系统。
  • FIPS评分在早期TIPS植入患者中预后区分度不足。

研究设计与样本

  • 回顾性研究,共纳入1871例因腹水或静脉曲张出血二级预防行TIPS的患者。
  • 训练集为80%患者(n=1496),验证集为20%患者(n=375)。
  • 另纳入290例因静脉曲张出血行早期TIPS的患者作为另一验证队列。
  • 使用Cox回归模型构建包含显著预后因素的预测模型。

主要发现

  • 年龄、胆红素、白蛋白和肌酐是最重要的预后因素。
  • 训练集中FIPS识别的高危患者中位生存期为5.0(3.1-6.9)个月。
  • 验证集中高危患者中位生存期为3.1(0.9-5.3)个月。
  • FIPS评分的预后区分度优于Child-Pugh、MELD、MELD-Na评分和胆红素-血小板模型。

关键数值与推荐

  • FIPS评分包含年龄、胆红素、白蛋白和肌酐四个参数。
  • 训练集高危患者中位生存期5.0(3.1-6.9)个月。
  • 验证集高危患者中位生存期3.1(0.9-5.3)个月。

临床怎么用

  • FIPS评分可用于择期TIPS术前风险分层,辅助临床决策。
  • FIPS评分不适用于早期TIPS患者的预后评估。

局限性

  • 研究为回顾性设计。
  • FIPS评分在早期TIPS植入患者中预后区分度不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Transjugular intrahepatic portosystemic shunt (TIPS) implantation is an effective and safe treatment for complications of portal hypertension. Survival prediction is important in these patients as they constitute a high-risk population. Therefore, the aim of our study was to develop an alternative prognostic model for accurate survival prediction after planned TIPS implantation. METHODS: A total of 1,871 patients with de novo TIPS implantation for ascites or secondary prophylaxis of variceal bleeding were recruited retrospectively. The study cohort was divided into a training set (80% of study patients; n = 1,496) and a validation set (20% of study patients; n = 375). Further, patients with early (preemptive) TIPS implantation due to variceal bleeding were included as another validation cohort (n = 290). Medical data and overall survival (OS) were assessed. A Cox regression model was used to create an alternative prediction model, which includes significant prognostic factors. RESULTS: Age, bilirubin, albumin and creatinine were the most important prognostic factors. These parameters were included in a new score named the Freiburg index of post-TIPS survival (FIPS). The FIPS score was able to identify high-risk patients with a significantly reduced median survival of 5.0 (3.1-6.9) months after TIPS implantation in the training set. These results were confirmed in the validation set (median survival of 3.1 [0.9-5.3] months). The FIPS score showed better prognostic discrimination compared to the Child-Pugh, MELD, MELD-Na score and the bilirubin-platelet model. However, the FIPS score showed insufficient prognostic discrimination in patients with early TIPS implantation. CONCLUSIONS: The FIPS score is superior to established scoring systems for the identification of high-risk patients with a worse prognosis following elective TIPS implantation. LAY SUMMARY: Implantation of a transjugular intrahepatic portosystemic shunt (TIPS) is a safe and effective treatment for patients with cirrhosis and clinically significant portal hypertension. However, risk stratification is a major challenge in these patients as currently available scoring systems have major drawbacks. Age, bilirubin, albumin and creatinine were included in a new risk score which was named the Freiburg index of post-TIPS survival (FIPS). The FIPS score can identify patients at high risk and may guide clinical decision making.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Bettinger D, Sturm L, Pfaff L, et al. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. J Hepatol. 2021. PMID: 33508376. doi:10.1016/j.jhep.2021.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。